Shane William Charles Kovacs is CH. OPERATING & FINANCIAL OFF. at Olema Pharmaceuticals, Inc. (OLMA). They have made 3 open-market trades across 1 company since 2014, most recently 2026-01-15.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PTCT | 37,850 | $2.5M |
| OLMA | 139,727 | $1.4M |
| Total | $3.9M |
Shares reported on the most recent Form 4, priced at the 2026-01-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OLMA | SELL | 2026-01-13 | 2026-01-15 | $28.70 | $3.0M | -15.7% | -22.4% | -43.5% |
| OLMA | SELL | 2024-12-10 | 2024-12-11 | $9.12 | $474K | -24.9% | -39.9% | -48.4% |
| OLMA | SELL | 2023-11-21 | 2023-11-22 | $14.37 | $529K | -5.4% | +1.0% | +5.1% |
| PTCT | SELL · 10b5-1 | 2015-05-22 | 2015-05-22 | $55.41 | $4.6M | -28.3% | -2.3% | -2.3% |
| PTCT | SELL · 10b5-1 | 2014-05-22 | 2014-05-23 | $14.74 | $24K | -28.3% | -2.3% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.